Report Company Directory

Colt Resources Inc.

• Ford Equity International Rating and Forecast Report by Ford Equity Research

COLTENE Holding AG

• Coltene Holding AG: 1 director by SmartInsider
• Ordentliche Generalversammlung – Aktionäre genehmigen alle Anträge des Verwaltungsrats by EQS Group AG
• Annual General Meeting – Shareholders approve all proposals of the Board of Directors by EQS Group AG
• Annual General Meeting - Shareholders approve all proposals of the Board of Directors by EQS Group AG
• Ordentliche Generalversammlung - Aktionäre nehmen alle Anträge des Verwaltungsrats an by EQS Group AG
• COLTENE HOLDING sees an upgrade to Slightly Positive due to a better fundamental star rating by TheScreener
• STMN.S: Straumann - Feedback from Credit Suisse Equity Forum Switzerland 2021 by Credit Suisse
• Top Of The Charts - A review of the week's best reads by Credit Suisse
• MEDX.S: Medmix - Mixing growth and repositioning opportunities: initiate at Outperform by Credit Suisse
• STMN.S: Straumann - Strong Q3 sales trends support our growth case. Eyes now on the upcoming CMD by Credit Suisse

Colucid Pharmaceuticals Inc

• CoLucid Pharmaceuticals Inc (CLCD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData Plc
• INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of CoLucid Pharmaceuticals, Inc. to Eli Lilly & Co. for $46.50 Per Share is Fair to Shareholders by BusinessWire
• Bragar Eagel & Squire, P.C. Is Investigating the Board of Directors of CoLucid Pharmaceuticals, Inc. (CLCD) on Behalf of Stockholders and Encourages Investors to Contact the Firm by BusinessWire
• INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information by BusinessWire
• INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of CoLucid Pharmaceuticals, Inc. to Eli Lilly & Co. for $46.50 Per Share is Fair to Shareholders -- CLCD by BusinessWire
• SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information by BusinessWire
• Robbins Arroyo LLP: Acquisition of CoLucid Pharmaceuticals, Inc. (CLCD) by Eli Lilly and Company (LLY) May Not Be in Shareholders' Best Interests by BusinessWire
• COLUCID PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Eli Lilly and Company May be Unfair to Shareholders by BusinessWire
• COLUCID PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout by BusinessWire

COLUMBIA ACORN EMERGING MARKET FUND

COLUMBIA ACORN FUND